What can modern statistics offer imaging neuroscience?

Statistical Methods in Medical Research

Volumn 12, Issue 5, 2003, Pages 447-469

  Lange, Nicholas ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LORAZEPAM; PLACEBO; RIVASTIGMINE; SCOPOLAMINE;

ALZHEIMER DISEASE; ANATOMY; BIOSTATISTICS; BRAIN DISEASE; BRAIN FUNCTION; CLINICAL TRIAL; CYTOARCHITECTURE; DRUG EFFECT; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; LONGITUDINAL STUDY; MATHEMATICAL ANALYSIS; MEMORY; MEMORY DISORDER; MICROSCOPY; NEUROSCIENCE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SCHIZOPHRENIA; STATISTICAL ANALYSIS; STATISTICAL MODEL; STEREOLOGY;

ALZHEIMER DISEASE; BRAIN MAPPING; GABA MODULATORS; HIPPOCAMPUS; HUMANS; LORAZEPAM; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MODELS, STATISTICAL; MUSCARINIC ANTAGONISTS; OXYGEN; SCHIZOPHRENIA; SCOPOLAMINE;

EID: 0242636976     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1191/0962280203sm342ra     Document Type: Review

References (67)

1. Breiman L. Statistical modeling: The two cultures (with discussion). Statistical Science 2001; 16: 199-231.
2. Pregibon D. ENAR President's Invited Address: Some Aspects of Technology in Statistical Practice. Charlotte, NC, USA, 2001.
3. Lange N, Strother SC, Anderson JR, et al. Plurality and resemblance in fMRI data analysis. NeuroImage 1999; 10: 282-303.
4. Lange N. Statistical procedures for functional MRI. In: Moonen C, Bandettini, PA, eds. Medical Radiology - Diagnostic Imaging and Radiation Oncology, Volume: Functional MRI. New York: Springer Verlag, 1999.
5. Crick F. The Astonishing Hypothesis: The Scientific Search for the Soul. New York: Charles Scribner and Sons, 1994.
6. Nauta WJH. The problem of the frontal lobe: A reinterpretation. Journal of Psychiatric Research 1971; 8: 167-87.
7. Goldman-Rakic PS, Selemon LD, Schwartz ML. Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience 1984; 12(3): 719-43.
8. Papez JW. A proposed mechanism of emotion. Archives of Neurological Psychiatry 1937; 38: 725-43.
9. Mesulam MM. Principles of Behavioral Neurology. Philadelphia, PA: FA Davis, 1985.
10. Scoville WB, Milner B. Loss of recent memory after bilateral hippocampal lesions. Journal of Neurology, Neurosurgery and Psychiatry 1957; 20: 11-21.
11. Eichenbaum H, Cohen NJ. Cognitive Neuroscience of Memory. Oxford: Oxford University Press, 2001.
12. Freund TF, Buzsaki G. Interneurons of the hippocampus. Hippocampus 1996; 6: 347-470.
13. Benes FM, Berretta S. GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001; 25(1): 1-27.
14. Berretta S, Lange N, Bhattacharryya S, Sebro R, Garces J, Benes FM. Long term effects of amygdala GABA blockade on specific subpopulations of hippocampal interneurons. In revision, Hippocampus.
15. West MJ, Coleman PD, Flodd DG, Trosco JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994; 344: 769-72.
16. Lawlor BA. Non-cognitive disturbances in Alzheimer's disease. Human Psychopharmacology 1994; 9: 33-96.
17. DSM-IV. Diagnostic Criteria from DSM-IV. Washington, D.C.: American Psychiatric Association, 1994.
18. Szeszko PR, Strous RD, Goldman RS et al. Neuropsychological correlates of hippocampal volumes in patients experiencing a first episode of schizophrenia. American Journal of Psychiatry 2002; 159(2): 217-26.
19. Heckers S, Rauch SL, Goff D et al. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nature Neuroscience 1998; 1(4): 318-23.
20. Heckers S. Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 2001; 11: 520-28.
21. Ragland JD, Gur RC, Raz J et al. Effect of schizophrenia on frontotemporal activity during word encoding and recognition: A PET cerebral blood flow study. American Journal of Psychiatry 2001; 158(7): 1114-25.
22. Lange N. Statistical approaches to human brain mapping by functional magnetic resonance imaging. Statistics in Medicine 1996; 15: 389-428.
23. Cabeza R, Nyberg L. Imaging cognition II: An empirical review of 275 PET and fMRI studies. Journal of Cognitive Neuroscience 2000; 12(1): 1-47.
24. Schacter DL, Wagner AD. Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval. Hippocampus 1999; 9: 7-24.
25. Adler RJ, Hasofer AM. Level crossing of random fields. Annals of Probability 1976; 4: 1-12.
26. Adler RJ. The Geometry of Random Fields. New York: Wiley, 1981.
27. Worsley KJ, Evans AC, Marrett S, Neelin P. Determining the number of statistically significant areas of activation in subtracted studies from PET. Journal of Cerebral Blood Flow and Metabolism 1992; 12: 900-18.
28. Worsley KJ. Local maxima and the expected Euler characteristic of excursion sets of chi-squared, F, and t fields. Advances in Applied Probability 1994; 26: 13-42.
29. Sperling R, Greve D, Dale A et al. MRI detection of pharmacologically induced memory impairment. Proceedings of the National Academy of Science USA 2002; 99: 455-60.
30. Hardman JG, Limbird LE (eds). Goodman and Gilman's, The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1996.
31. Ghoneim MM, Mewaldt SP. Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory. Psychopharmacologia 1975; 44(3): 257-62.
32. Ghoneim MM, Mewaldt SP. Studies on human memory: The interactions of diazepam, scopolamine, and physostigmine. Psychopharmacology (Berl) 1977; 52(1): 1-6.
33. Curran HV, Pooviboonsuk P, Dalton JA, Lader MH. Differentiating the effects of centrally acting drugs on arousal and memory: An event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology (Berl) 1988; 135(1): 27-36.
34. Thiel CM, Henson RNA, Morris JS, Friston KJ, Dolan RJ. Pharmacological modulation of behavioral and neuronal correlates of repetition priming. Journal of Neuroscience 2001; 21(17): 6846-52.
35. Loubinoux I, Pariente J, Boulanouar K et al. A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: Double-blind, placebo-controlled, fMRI study in healthy subjects. NeuroImage 2002; 15: 26-36.
36. Rombouts SARB, Barkhof F, Van Meel CS, Schelten P. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzhiemer's disease. Journal of Neurology Neurosurgery Psychiatry 2002; 73: 665-71.
37. Genovese CR, Noll DC, Eddy WF. Estimating test-retest reliability in fMRI I: Statistical methodology. Magnetic Resonance in Medicine 1997; 38: 497-507.
38. Machielsen WC, Rombouts SA, Barkhof F, Scheltens P, Witter MP. FMRI of visual encoding: Reproducibility of activation. Human Brain Mapping 2000; 9(3): 156-64.
39. McGonigle DJ, Howseman AM, Athwal BS, Friston KJ, Frackowiak RS, Holmes AP. Variability in fMRI: An examination of intersession differences. NeuroImage 2000; 11: 708-34.
40. McCulloch CE, Searle SR. Generalized, Linear and Mixed Models. New York: John Wiley & Sons, Inc., 2001.
41. Pinheiro JC, Bates DM. Mixed-Effects Models in S and S-PLUS. New York: Springer, 2000.
42. Hinkelmann K, Kempthorne O. Design and Analysis of Experiments. Volume I: Introduction to Experimental Design. New York: John Wiley & Sons, Inc. 1994.
43. Lange N, Zeger SL. Non-linear Fourier time series analysis for human brain mapping by functional magnetic resonance imaging (with discussion). Journal of the Royal Statistical Society Series C 1997; 46(1): 1-29.
44. Liao CH, Worsley KJ, Poline JB, Duncan GH, Evans AC. Estimating the delay of the fMRI response. NeuroImage 2002; 16: 593-606.
45. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B, 1995; 57: 289-300.
46. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage 2002; 15: 870-78.
47. Desimone R. Neural mechanisms for visual memory and their role in attention. Proceedings of the National Academy of Science USA 1996; 93: 13494-99.
48. Weibel ER. Stereological Methods, Vol I: Practical Methods for Biological Morphometry. New York: Academic Press, 1979.
49. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the disector. Journal of Microscopy 1984; 134(2): 127-36.
50. Howard CV, Reed M. Unbiased Stereology: Three-Dimensional Measurement in Microscopy. New York: Springer Verlag, 1985.
51. Baddeley A. Stereology. In: Spatial Statistics and Digital Image Analysis. Panel of Spatial Statistics and Image Processing, Board on Mathematical Science, Commission on Physical Sciences, Mathematics and Applications, and the National Research Council. Washington, D.C.: National Academy Press, 1991: 181-216.
52. Baddeley AJ. A Crash Course in Stochastic Geometry. In: Barndorff-Nielsen O, Kendall W, Lieshout MNM eds. London: Chapman & Hall/CRC, 1999: 1-35.
53. Baddeley A. Is stereology 'unbiased'? Comment on a paper by Benes and Lange. Trends in Neuroscience 2001; 24: 375-76.
54. Bogerts B, Meertz E, Schonfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Archives of General Psychiatry 1985; 42(8): 784-91.
55. McCarley RW, Wible CG, Frumin M et al. MRI anatomy of schizophrenia. Biological Psychiatry 1999; 45: 1099-1119.
56. The impact of recent stereological advances on quantitative studies of the nervous system. Journal of Neuroscience Methods 1986; 18: 39-78.
57. Lange N, Lake S, Sperling R et al. Two macroscopic and microscopic brain imaging studies of human hippocampus in early Alzheimer's disease and schizophrenia research. In Press, Statistics in Medicine.
58. Benes FM, Lange N. Two-dimensional versus three-dimensional cell counting: A practical perspective. Trends in Neuroscience 2001; 24: 11-17.
59. Benes FM, Lange N. Reconciling theory and practice in cell counting. Trends in Neuroscience 2001; 24: 378-380.
60. Soille P. Morphological Image Analysis: Principles and Applications. Berlin: Springer Verlag, 1998.
61. Vincent L. Current topics in applied morphological image analysis. In: Barndorff-Neilsen OE, Kendall WS, van Lieshout MNM eds. Stochastic Geometry: Likelihood and Computation. London: Chapman and Hall/CRC, 1999: 199-283.
62. Young D, Ma J, Cherkerzian S et al. Automated identification of Fos expression. Biostatistics 2001; 2: 351-64.
63. Von Bartheld CS. Systematic bias in an 'unbiased' neuronal counting technique. Anatomical Record 1999; 257(4): 119-20.
64. Von Bartheld CS. Comparison of 2-D and 3-D counting: The need for calibration and common sense. Trends in Neuroscience 2001; 24(9): 504-506.
65. Roy CS, Sherrington CS. The regulation of blood supply in the brain. Journal of Physiology (London) 1890; 11: 85-108.
66. Everitt BS, Bullmore E. Mixture model mapping of brain activation in functional magnetic resonance images. Human Brain Mapping 1999; 7: 1-14.
67. Lange N, Laird NM. The effect of covariance structure on variance estimation in balanced growth-curve models with random parameters. Journal of the American Statistical Association 1989; 84: 241-47.